FindTrial
Sign In

The effect of local infiltration of ropivacaine in postoperative pain and ERAS

The effect of local infiltration of ropivacaine in postoperative pain and ERAS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020630
Enrollment
Unknown
Registered
2019-01-11
Start date
2017-07-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain after surgery

Interventions

Group 1:ropivacaine
Group 2:normal saline solution

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients need accept surgery because of the hepatobiliary diseases; 2. Male and female aged 20-80 years, weight 50-80 kg; 3. the experiment group accept the infiltration of ropivacaine, the same in control group with normal saline solution.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had acute cholecystitis, serious chronic pain disease, history of alcohol abuse, tranquilizer treatment before surgery, cognitive impairment, or history of allergy to any of the drugs used in the study.

Design outcomes

Primary

MeasureTime frame
VAS;Heart rate;MAP;epinephrine;norepinephrine;accumulate of sufentanil;—

Countries

China

Contacts

Public ContactBin Jin

Department of general Surgery, Qilu Hospital of Shandong University, Jinan, China

jinbin9449@126.com+86 18560085136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026